Cancer Gene Therapy, Published online: 11 October 2026; doi:10.1038/s41417-026-01088-7 LAMB3 orchestrates EGFR-MAPK-PKM cascade to promote glycolytic reprogramming and progression in laryngeal carcinoma
Lu Zhang, Cheng Kang, Kai Wang. LAMB3 orchestrates EGFR-MAPK-PKM cascade to promote glycolytic reprogramming and progression in laryngeal carcinoma. // Cancer Gene Therapy. – 2026. – DOI: 10.1038/s41417-026-01088-7. – URL: https://www.nature.com/articles/s41417-026-01088-7
Lu Zhang, Cheng Kang, & Kai Wang (2026). LAMB3 orchestrates EGFR-MAPK-PKM cascade to promote glycolytic reprogramming and progression in laryngeal carcinoma. Cancer Gene Therapy. https://doi.org/10.1038/s41417-026-01088-7
Lu Zhang, et al. “LAMB3 orchestrates EGFR-MAPK-PKM cascade to promote glycolytic reprogramming and progression in laryngeal carcinoma.” Cancer Gene Therapy, 2026. doi:10.1038/s41417-026-01088-7.
@article{Zhang2026,
title = {LAMB3 orchestrates EGFR-MAPK-PKM cascade to promote glycolytic reprogramming and progression in laryngeal carcinoma},
author = {Zhang, Lu and Kang, Cheng and Wang, Kai},
journal = {Cancer Gene Therapy},
year = {2026},
doi = {10.1038/s41417-026-01088-7},
url = {https://www.nature.com/articles/s41417-026-01088-7}
}